I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Cather, Jennifer
60
results:
Search for persons
X
Format
Online (60)
Mediatypes
Articles (Online) (46)
Bookchapter (Online) (1)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
357 The effect of upadacitinib on the genital region in mod..:
Cather, Jennifer
;
Magnolo, Nina
;
Cameron, Michael
...
British Journal of Dermatology. 188 (2023) Supplement_2 - p. , 2023
Link:
https://doi.org/10.1093/..
?
2
Deucravacitinib, an oral, selective, allosteric tyrosine ki..:
Bagel, Jerry
;
Armstrong, April W.
;
Warren, Richard B.
...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s117 , 2023
Link:
https://doi.org/10.25251..
?
3
Tapinarof Cream 1% Once Daily: Disease Control Off Treatmen..:
Strober, Bruce
;
Zeichner, Joshua A.
;
Desai, Seemal R.
...
SKIN The Journal of Cutaneous Medicine. 7 (2023) 2 - p. s125 , 2023
Link:
https://doi.org/10.25251..
?
4
A Review of Phase 3 Trials of Dupilumab for the Treatment o..:
Cather, Jennifer
;
Young, Melodie
;
DiRuggiero, Douglas C.
...
Dermatology and Therapy. 12 (2022) 9 - p. 2013-2038 , 2022
Link:
https://doi.org/10.1007/..
?
5
Deucravacitinib, an oral, selective tyrosine kinase 2 inhib..:
Bagel, Jerry
;
Armstrong, April
;
Warren, Richard
...
SKIN The Journal of Cutaneous Medicine. 6 (2022) 6 - p. s47 , 2022
Link:
https://doi.org/10.25251..
?
6
33817 Bimekizumab efficacy and safety in patients with mode..:
Lebwohl, Mark
;
Ghoreschi, Kamran
;
Strober, Bruce
...
Journal of the American Academy of Dermatology. 87 (2022) 3 - p. AB145 , 2022
Link:
https://doi.org/10.1016/..
?
7
25357 Malignancies related to study drug and leading to dis..:
Friedman, Adam
;
Vender, Ronald B.
;
Desai, Mital
...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB56 , 2021
Link:
https://doi.org/10.1016/..
?
8
26691 Rapid and concurrent improvements in the signs and sy..:
Lio, Peter
;
Soung, Jennifer
;
Cather, Jennifer
...
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB113 , 2021
Link:
https://doi.org/10.1016/..
?
9
14161 Ixekizumab is superior to placebo for the treatment o..:
Paller, Amy S.
;
Alejandro Magariños, Gabriel
;
Pinter, Andreas
...
Journal of the American Academy of Dermatology. 83 (2020) 6 - p. AB20 , 2020
Link:
https://doi.org/10.1016/..
?
10
15966 Rates of malignancies through 5 years of tildrakizuma..:
Cather, Jennifer
;
Nardone, Beatrice
;
Parno, Jeff
...
Journal of the American Academy of Dermatology. 83 (2020) 6 - p. AB165 , 2020
Link:
https://doi.org/10.1016/..
?
11
Long‐term efficacy and safety of topical glycopyrronium tos..:
Hebert, Adelaide A.
;
Glaser, Dee Anna
;
Green, Lawrence
...
Pediatric Dermatology. 37 (2020) 3 - p. 490-497 , 2020
Link:
https://doi.org/10.1111/..
?
12
A series of critically challenging case scenarios in modera..:
Strober, Bruce
;
Berger, Emily
;
Cather, Jennifer
...
Journal of the American Academy of Dermatology. 61 (2009) 1 - p. S1-S46 , 2009
Link:
https://doi.org/10.1016/..
?
13
Alefacept revisited: Our 3-year clinical experience in 200 ..:
Perlmutter, Amy
;
Cather, Jennifer
;
Franks, Billy
..
Journal of the American Academy of Dermatology. 58 (2008) 1 - p. 116-124 , 2008
Link:
https://doi.org/10.1016/..
?
14
Atypical CD8+ Cutaneous T-Cell Lymphoma After Immunomodulat..:
Berthelot, Cindy
;
Cather, Jennifer
;
Jones, Dan
.
Clinical Lymphoma and Myeloma. 6 (2006) 4 - p. 329-332 , 2006
Link:
https://doi.org/10.3816/..
?
15
Efalizumab: A Viewpoint by Jennifer Cather:
Cather, Jennifer
American Journal of Clinical Dermatology. 6 (2005) 2 - p. 119-120 , 2005
Link:
https://doi.org/10.2165/..
1-15